Interpace Biosciences Inc Short ratio
What is the Short ratio of Interpace Biosciences Inc?
The Short ratio of Interpace Biosciences Inc is 0.19
What is the definition of Short ratio?
Short ratio is the number of shares sold short divided by the average daily volume.
= short interest / average daily volume
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Short ratio of companies in the Health Care sector on NASDAQ compared to Interpace Biosciences Inc
What does Interpace Biosciences Inc do?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Companies with short ratio similar to Interpace Biosciences Inc
- Australian REIT Income Fund has Short ratio of 0.18
- Enlighta has Short ratio of 0.18
- Tearlach Resources has Short ratio of 0.18
- Academy Metals has Short ratio of 0.18
- Guangshen Railway Co has Short ratio of 0.18
- BlackRock Municipal Income Investment Quality Trust has Short ratio of 0.18
- Interpace Biosciences Inc has Short ratio of 0.19
- PowerOre has Short ratio of 0.20
- ALX Resources has Short ratio of 0.20
- Serabi Gold plc has Short ratio of 0.20
- Gratomic has Short ratio of 0.20
- Benton Resources has Short ratio of 0.20
- Act II Global Acquisition has Short ratio of 0.20